1,210 results on '"Wilcox, Mark H."'
Search Results
2. European Practice for CDI Treatment
3. Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance
4. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
5. A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways
6. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
7. How to: Clostridioides difficile infection in children
8. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance
9. Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection
10. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
11. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples
12. Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies
13. Public health case for microbiome-sparing antibiotics and new opportunities for drug development.
14. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
15. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
16. Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing
17. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model
18. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)
19. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland
20. European Practice for CDI Treatment
21. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
22. The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials
23. The potential of microbiome replacement therapies for Clostridium difficile infection
24. Can SARS-CoV-2 be transmitted via faeces?
25. Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials
26. Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
27. Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
28. Evaluating the impact of testing strategies for the detection of nosocomial COVID-19 in English hospitals through data-driven modeling
29. Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
30. Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
31. A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens : REVIVE-1
32. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children : 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
33. Clostridium difficile
34. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains
35. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records
36. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis
37. Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
38. Tracking COVID-19 via sewage
39. Is there a causal relationship between trehalose consumption and Clostridioides difficile infection?
40. Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing
41. Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative
42. The Molecular Epidemiology of Clostridioides difficile Infection in Central India: A Prospective Observational Cohort Study
43. Molecular testing in suspected infectious diarrhoea—the value of negative results
44. A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens
45. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
46. Effects of control interventions on Clostridium difficile infection in England: an observational study
47. Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon
48. 271 - Clostridial and Clostridioides Infections
49. Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series
50. Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.